ABIOMED INC Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Abiomed Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2013 to 2021.
  • Abiomed Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending September 30, 2022 was $139M, a 106% increase year-over-year.
  • Abiomed Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending September 30, 2022 was $341M, a 60.8% increase year-over-year.
  • Abiomed Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was $191M, a 33.9% decline from 2020.
  • Abiomed Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was $288M, a 12.2% increase from 2019.
  • Abiomed Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2019 was $257M, a 2.48% decline from 2018.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $191M -$97.7M -33.9% Apr 1, 2021 Mar 31, 2022 10-K 2022-05-20
2020 $288M +$31.4M +12.2% Apr 1, 2020 Mar 31, 2021 10-K 2022-05-20
2019 $257M -$6.54M -2.48% Apr 1, 2019 Mar 31, 2020 10-K 2022-05-20
2018 $263M +$103M +64.2% Apr 1, 2018 Mar 31, 2019 10-K 2021-05-21
2017 $160M +$69.1M +75.6% Apr 1, 2017 Mar 31, 2018 10-K 2020-05-21
2016 $91.3M +$25.5M +38.7% Apr 1, 2016 Mar 31, 2017 10-K 2019-05-23
2015 $65.8M +$37.1M +129% Apr 1, 2015 Mar 31, 2016 10-K 2018-05-24
2014 $28.8M +$20.2M +237% Apr 1, 2014 Mar 31, 2015 10-K 2017-05-25
2013 $8.53M Apr 1, 2013 Mar 31, 2014 10-K 2016-05-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.